These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9814492)

  • 21. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries.
    Sanno N; Jin L; Qian X; Osamura RY; Scheithauer BW; Kovacs K; Lloyd RV
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1974-82. PubMed ID: 9177416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction.
    Evans CO; Young AN; Brown MR; Brat DJ; Parks JS; Neish AS; Oyesiku NM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3097-107. PubMed ID: 11443173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level.
    Pagotto U; Marsicano G; Fezza F; Theodoropoulou M; Grübler Y; Stalla J; Arzberger T; Milone A; Losa M; Di Marzo V; Lutz B; Stalla GK
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2687-96. PubMed ID: 11397872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ghrelin and growth hormone (GH) secretagogue receptor (GHSR) mRNA expression in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Osamura RY; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Jun; 54(6):759-68. PubMed ID: 11422110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone secretagogue receptor expression in human pituitary tumors.
    Skinner MM; Nass R; Lopes B; Laws ER; Thorner MO
    J Clin Endocrinol Metab; 1998 Dec; 83(12):4314-20. PubMed ID: 9851770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of pituitary homeo box 1 (Ptx1) in human non-neoplastic pituitaries and pituitary adenomas.
    Tahara S; Kurotani R; Sanno N; Takumi I; Yoshimura S; Osamura RY; Teramoto A
    Mod Pathol; 2000 Oct; 13(10):1097-108. PubMed ID: 11048804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of thyrotrophin-releasing hormone receptor 1 messenger ribonucleic acid in human pituitary adenomas.
    Kim K; Arai K; Sanno N; Teramoto A; Shibasaki T
    Clin Endocrinol (Oxf); 2001 Mar; 54(3):309-16. PubMed ID: 11298082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of guanylyl cyclase-B (GC-B/NPR2) receptors in normal human fetal pituitaries and human pituitary adenomas implicates a role for C-type natriuretic peptide.
    Thompson IR; Chand AN; King PJ; Ansorge O; Karavitaki N; Jones CA; Rahmutula D; Gardner DG; Zivkovic V; Wheeler-Jones CP; McGonnell IM; Korbonits M; Anderson RA; Wass JA; McNeilly AS; Fowkes RC
    Endocr Relat Cancer; 2012 Aug; 19(4):497-508. PubMed ID: 22645228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
    Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
    Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homologous and heterologous down-regulation of leptin receptor messenger ribonucleic acid in rat adrenal gland.
    Tena-Sempere M; Pinilla L; González LC; Casanueva FF; Diéguez C; Aguilar E
    J Endocrinol; 2000 Dec; 167(3):479-86. PubMed ID: 11115775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
    Garcia EA; Trivellin G; Aflorei ED; Powell M; Grieve J; Alusi G; Pobereskin L; Shariati B; Cudlip S; Roncaroli F; Mendoza N; Grossman AB; Harper EA; Korbonits M
    J Clin Endocrinol Metab; 2013 Dec; 98(12):E1918-26. PubMed ID: 24152687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of leptin receptor gene expression in the anterior pituitary of human growth hormone-releasing hormone transgenic mice.
    Cai A; Hyde JF
    Endocrinology; 1998 Jan; 139(1):420-3. PubMed ID: 9421442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression of adrenomedullin, leptin, their receptors and neuropeptide Y in hormone-secreting and non-functioning pituitary adenomas, meningiomas and malignant intracranial tumours in humans.
    Knerr I; Schuster S; Nomikos P; Buchfelder M; Dötsch J; Schoof E; Fahlbusch R; Rascher W
    Neuropathol Appl Neurobiol; 2001 Jun; 27(3):215-22. PubMed ID: 11489141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.
    Jin L; Qian X; Kulig E; Sanno N; Scheithauer BW; Kovacs K; Young WF; Lloyd RV
    Am J Pathol; 1997 Aug; 151(2):509-19. PubMed ID: 9250163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PTR-3173 (somatoprim), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion.
    Shimon I; Rubinek T; Hadani M; Alhadef N
    J Endocrinol Invest; 2004 Sep; 27(8):721-7. PubMed ID: 15636423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urocortin expression in human pituitary gland and pituitary adenoma.
    Iino K; Sasano H; Oki Y; Andoh N; Shin RW; Kitamoto T; Totsune K; Takahashi K; Suzuki H; Nagura H; Yoshimi T
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3842-50. PubMed ID: 9360550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
    Hofland LJ; de Herder WW; Waaijers M; Zuijderwijk J; Uitterlinden P; van Koetsveld PM; Lamberts SW
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3336-43. PubMed ID: 10487708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
    Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.